MedTrace Logo

Integrated Medical, Surgical and Physiotherapy Care for Pregnant Women With Chronic Diseases

NCT07589946 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-05-15

No results posted yet for this study

Summary

This non-randomized controlled quasi-experimental study evaluates the effectiveness of an integrated medical-surgical and physiotherapy community-based care model for pregnant women with chronic diseases. Eligible pregnant women aged 18 years or older and enrolled before 20 weeks of gestation are allocated to either an intervention group receiving coordinated multidisciplinary care plus individualized physiotherapy or a control group receiving standard antenatal care. The intervention includes standardized clinical pathways, care coordination, self-management education, community linkages, and physiotherapy exercises tailored to gestational age, chronic disease type, and baseline functional assessment. Outcomes are assessed at baseline, delivery, and 6 weeks postpartum and include maternal complications, neonatal outcomes, quality of life, treatment adherence, patient satisfaction, healthcare utilization, and maternal physical-function indicators.

Conditions

  • Pregnancy
  • Pregnancy-Related Pain
  • Musculoskeletal Disorders
  • Physical Therapy

Interventions

DEVICE

Physiotherapy-based Care

* Aerobic exercises for cardiovascular endurance. * Resistance exercises to improve muscle strength. * Posture correction exercises to improve body alignment. * Core stabilization exercises to improve overall strength and stability. * Pelvic floor muscle training for better support during pregnancy. * Breathing exercises to enhance relaxation and reduce

OTHER

control group

The participants in the control group received the usual routine antenatal care without the added physiotherapy program. The focus was on the management of chronic diseases during pregnancy but did not include the structured exercise regimen provided to the intervention group.

Sponsors & Collaborators

  • Sinai University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-15
Primary Completion
2026-03-01
Completion
2026-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07589946 on ClinicalTrials.gov